Clinical & Experimental Metastasis

, Volume 27, Issue 7, pp 505–515 | Cite as

Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells

  • Adriana Soto-Guzman
  • Napoleon Navarro-Tito
  • Luis Castro-Sanchez
  • Raul Martinez-Orozco
  • Eduardo Perez SalazarEmail author
Research Paper


Epidemiological and animal studies suggest an association between dietary fatty acids and an increase risk of developing breast cancer. Obesity, which is characterized by hyperlipidemia and an elevation of circulating free fatty acids (FFAs), is also associated with enhanced cancer risk. In breast cancer cells, the FFA oleic acid (OA) induces migration, proliferation, prolong survival, invasion, an increase in cellular Ca2+ concentration, MEK1/2, ERK1/2, FAK and Src activation. However, the role of OA on MMP-9 secretion and invasion has not been studied in detail. We demonstrate here that stimulation of MDA-MB-231 breast cancer cells with 200 μM OA induces an increase on MMP-9 secretion through a PKC, Src, and EGFR-dependent pathway, as revealed by gelatin zymography assays. Furthermore, microtubule network mediates MMP-9 secretion induced by OA. In contrast, OA does not induce an increase on MMP-9 secretion in MCF10A cells, whereas it does not induce MMP-9 secretion in MCF12A mammary non-tumorigenic epithelial cells. In addition, OA induces invasion through an EGFR, Gi/Go proteins, MMPs, PKC and Src-dependent pathway, but it is not able to promote invasion in non-invasive MCF-7 breast cancer cells. In summary, our findings demonstrate that OA promotes an increase on MMP-9 secretion and invasion through a PKC, Src, and EGFR-dependent pathway in breast cancer cells.


Breast cancer Oleic acid MMP-9 Invasion 



We are grateful to Nora Ruiz for her technical assistance. This work was supported by grants from CONACYT (43370 and 83802). A. S-G is a recipient of a postdoctoral fellowship from ICyTDF. L. C-S, R. M-O and N. N-T were supported by a CONACYT predoctoral training grant.

Supplementary material

10585_2010_9340_MOESM1_ESM.tif (1.7 mb)
Oleic acid induces invasiveness in MDA-MB-231 breast cancer cells MDA-MB-231 cells held in suspension were treated for 2 h in the absence (-) or presence (+) of 12 μM mitomicyn C (Mit.C), as indicated and then cells were plated on the top of matrigel and treated with 200 μM oleic acid for various times, as indicated. Cell invasion was evaluated after incubation. (TIFF 1733 kb)


  1. 1.
    Welsch CW (1992) Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 52(7 Suppl):2040s–2048sPubMedGoogle Scholar
  2. 2.
    Rose DP (1997) Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66(suppl 6):1513S–1522SPubMedGoogle Scholar
  3. 3.
    Lee MM, Lin SS (2000) Dietary fat and breast cancer. Annu Rev Nutr 20:221–248CrossRefPubMedGoogle Scholar
  4. 4.
    Fay MP, Freedman LS, Clifford CK (1997) Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res 57:3979–3988PubMedGoogle Scholar
  5. 5.
    Felber JP, Golay A (2002) Pathways from obesity to diabetes. Int J Obes Relat Metab Disord 26(suppl 2):S39–S45CrossRefPubMedGoogle Scholar
  6. 6.
    Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591CrossRefPubMedGoogle Scholar
  7. 7.
    McArthur MJ, Atshaves BP, Frolov A (1999) Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40:1371–1383PubMedGoogle Scholar
  8. 8.
    Ferre P (2004) The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53(suppl 1):S43–S50CrossRefPubMedGoogle Scholar
  9. 9.
    Louet JF, Chatelain F, Decaux JF (2001) Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway. Biochem J 354(Pt 1):189–197CrossRefPubMedGoogle Scholar
  10. 10.
    Yonezawa T, Katoh K, Obara Y (2004) Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem Biophys Res Commun 314:805–809CrossRefPubMedGoogle Scholar
  11. 11.
    Hirasawa A, Tsumaya K, Awaji T (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90–94CrossRefPubMedGoogle Scholar
  12. 12.
    Itoh Y, Kawamata Y, Harada M (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173–176CrossRefPubMedGoogle Scholar
  13. 13.
    Briscoe CP, Tadayyon M, Andrews JL (2003) The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278:11303–11311CrossRefPubMedGoogle Scholar
  14. 14.
    Brown AJ, Goldsworthy SM, Barnes AA (2003) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312–11319CrossRefPubMedGoogle Scholar
  15. 15.
    Xiong Y, Miyamoto N, Shibata K (2004) Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci USA 101:1045–1050CrossRefPubMedGoogle Scholar
  16. 16.
    Le Poul E, Loison C, Struyf S (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278:25481–25489CrossRefPubMedGoogle Scholar
  17. 17.
    Navarro-Tito N, Robledo T, Salazar EP (2008) Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Exp Cell Res 314:3340–3355CrossRefPubMedGoogle Scholar
  18. 18.
    Soto-Guzman A, Robledo T, Lopez-Perez M, Salazar EP (2008) Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells. Mol Cell Endocrinol 294:81–91CrossRefPubMedGoogle Scholar
  19. 19.
    Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Martinez-Orozco R, Salazar EP (2010) Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway. Int J Biochem Cell Biol 42:306–317CrossRefPubMedGoogle Scholar
  20. 20.
    Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M (2005) Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem 280:13285–13291CrossRefPubMedGoogle Scholar
  21. 21.
    Germain E, Chajes V, Cognault S, Lhuillery C, Bougnoux P (1998) Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer 75:578–583CrossRefPubMedGoogle Scholar
  22. 22.
    Przybytkowski E, Joly E, Nolan CJ, Hardy S, Francoeur AM, Langelier Y, Prentki M (2007) Upregulation of cellular triacylglycerol—free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells. Biochem Cell Biol 85:301–310CrossRefPubMedGoogle Scholar
  23. 23.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R (2004) Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: role of exogenous dietary fatty acids, p53–p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Int J Oncol 24:591–608PubMedGoogle Scholar
  24. 24.
    Martinez-Orozco R, Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Salazar EP (2010) Arachidonic acid promotes epithelial-to-mesenchymal-like transition inmammary epithelial cells MCF10A. Eur J Cell Biol 89:476–488CrossRefPubMedGoogle Scholar
  25. 25.
    Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387–2392CrossRefPubMedGoogle Scholar
  26. 26.
    Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300–308CrossRefPubMedGoogle Scholar
  27. 27.
    Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48:411–424CrossRefPubMedGoogle Scholar
  28. 28.
    Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174CrossRefPubMedGoogle Scholar
  29. 29.
    Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516CrossRefPubMedGoogle Scholar
  30. 30.
    Mendes O, Kim HT, Stoica G (2005) Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 22:237–246CrossRefPubMedGoogle Scholar
  31. 31.
    Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM (2004) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 10:7621–7628CrossRefPubMedGoogle Scholar
  32. 32.
    Duffy MJ, Maguire TM, Hill A, McDermott E, O’Higgins N (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2:252–257CrossRefPubMedGoogle Scholar
  33. 33.
    Jones JL, Glynn P, Walker RA (1999) Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189:161–168CrossRefPubMedGoogle Scholar
  34. 34.
    Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV, Salazar EP (2008) Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol 27:220–231CrossRefPubMedGoogle Scholar
  35. 35.
    Juarez J, Clayman G, Nakajima M, Tanabe KK, Saya H, Nicolson GL, Boyd D (1993) Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer 55:10–18CrossRefPubMedGoogle Scholar
  36. 36.
    Park MJ, Park IC, Hur JH, Rhee CH, Choe TB, Yi DH, Hong SI, Lee SH (2000) Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci Lett 290:201–204CrossRefPubMedGoogle Scholar
  37. 37.
    Simon C, Goepfert H, Boyd D (1998) Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92, 000 type IV collagenase secretion and in vitro invasion. Cancer Res 58:1135–1139PubMedGoogle Scholar
  38. 38.
    Vacaresse N, Lajoie-Mazenc I, Auge N, Suc I, Frisach MF, Salvayre R, Negre-Salvayre A (1999) Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ Res 85:892–899PubMedGoogle Scholar
  39. 39.
    Kim S, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH (2009) EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal 21:892–898CrossRefPubMedGoogle Scholar
  40. 40.
    Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D (2002) FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293:1174–1182CrossRefPubMedGoogle Scholar
  41. 41.
    Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D (2001) Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20:8066–8074CrossRefPubMedGoogle Scholar
  42. 42.
    Sliva D, English D, Lyons D, Lloyd FP Jr (2002) Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Biochem Biophys Res Commun 290:552–557CrossRefPubMedGoogle Scholar
  43. 43.
    Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771–15781PubMedGoogle Scholar
  44. 44.
    Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA (2000) SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 20:9018–9027CrossRefPubMedGoogle Scholar
  45. 45.
    Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N (2005) Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 65:1433–1441CrossRefPubMedGoogle Scholar
  46. 46.
    Pettersson F, Couture MC, Hanna N, Miller WH (2004) Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK. Oncogene 23:7053–7066CrossRefPubMedGoogle Scholar
  47. 47.
    Moss J, Vaughan M (1988) ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. Adv Enzymol Relat Areas Mol Biol 61:303–379PubMedGoogle Scholar
  48. 48.
    Imada K, Ito A, Sato T, Namiki M, Nagase H, Mori Y (1997) Hormonal regulation of matrix metalloproteinase 9/gelatinase B gene expression in rabbit uterine cervical fibroblasts. Biol Reprod 56:575–580CrossRefPubMedGoogle Scholar
  49. 49.
    Kim HS, Luo L, Pflugfelder SC, Li DQ (2005) Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 46:840–848CrossRefPubMedGoogle Scholar
  50. 50.
    Deery WJ, Weisenberg RC (1981) Kinetic and steady-state analysis of microtubules in the presence of colchicine. Biochemistry 20:2316–2324CrossRefPubMedGoogle Scholar
  51. 51.
    Wodnicka M, Pierzchalska M, Bereiter-Hahn J, Kajstura J (1992) Comparative study on effects of cytochalasins B and D on F-actin content in different cell lines and different culture conditions. Folia Histochem Cytobiol 30:107–111PubMedGoogle Scholar
  52. 52.
    Cortesio CL, Chan KT, Perrin BJ, Burton NO, Zhang S, Zhang ZY, Huttenlocher A (2008) Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol 180:957–971CrossRefPubMedGoogle Scholar
  53. 53.
    Lin KL, Su JC, Chien CM, Tseng CH, Chen YL, Chang LS, Lin SR (2010) Naphtho[1, 2-b]furan-4, 5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells. Toxicol In Vitro 24:1158–1167CrossRefPubMedGoogle Scholar
  54. 54.
    Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271:695–701CrossRefPubMedGoogle Scholar
  55. 55.
    Das R, Mahabeleshwar GH, Kundu GC (2004) Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. J Biol Chem 279:11051–11064CrossRefPubMedGoogle Scholar
  56. 56.
    Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, Hanks SK, Cheresh DA (2009) Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Res 69:1383–1391CrossRefPubMedGoogle Scholar
  57. 57.
    Curran S, Murray GI (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36:1621–1630CrossRefPubMedGoogle Scholar
  58. 58.
    Peyri N, Berard M, Fauvel-Lafeve F, Trochon V, Arbeille B, Lu H, Legrand C, Creoin M (2009) Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation. Anticancer Res 29:2347–2355PubMedGoogle Scholar
  59. 59.
    Augustin S, Berard M, Kellaf S, Peyri N, Fauvel-Lafeve F, Legrand C, He L, Crepin M (2009) Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells. Anticancer Res 29:1335–1343PubMedGoogle Scholar
  60. 60.
    Boyd NF, Stone J, Vogt KN, Connelly BS, Martin LJ, Minkin S (2003) Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 89:1672–1685CrossRefPubMedGoogle Scholar
  61. 61.
    Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjonneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quiros JR, Martinez C, Tormo MJ, Wirfalt E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762–771CrossRefPubMedGoogle Scholar
  62. 62.
    Byon CH, Hardy RW, Ren C, Ponnazhagan S, Welch DR, McDonald JM, Chen Y (2009) Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Lab Invest 89:1221–1228CrossRefPubMedGoogle Scholar
  63. 63.
    Kim MS, Lee EJ, Kim HR, Moon A (2003) p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 63:5454–5461PubMedGoogle Scholar
  64. 64.
    Kim JH, Lee KW, Lee MW, Lee HJ, Kim SH, Surh YJ (2006) Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target. FEBS Lett 580:385–392CrossRefPubMedGoogle Scholar
  65. 65.
    Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T, Moore MA, Yazawa K, Araki E, Tsuda H (1997) Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer 73:607–612CrossRefPubMedGoogle Scholar
  66. 66.
    Polette M, Huet E, Birembaut P, Maquart FX, Hornebeck W, Emonard H (1999) Influence of oleic acid on the expression, activation and activity of gelatinase A produced by oncogene-transformed human bronchial epithelial cells. Int J Cancer 80:751–755CrossRefPubMedGoogle Scholar
  67. 67.
    Hoshino D, Tomari T, Nagano M, Koshikawa N, Seiki M (2009) A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion. J Biol Chem 284:27315–27326CrossRefPubMedGoogle Scholar
  68. 68.
    Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C (2009) Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene 28:2466–2475CrossRefPubMedGoogle Scholar
  69. 69.
    Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15–33CrossRefPubMedGoogle Scholar
  70. 70.
    Hiscox S, Morgan L, Green T, Nicholson RI (2006) Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocr Relat Cancer 13(suppl 1):S53–S59CrossRefPubMedGoogle Scholar
  71. 71.
    Zou D, Yoon HS, Anjomshoaa A, Perez D, Fukuzawa R, Guilford P, Humar B (2009) Increased levels of active c-Src distinguish invasive from in situ lobular lesions. Breast Cancer Res 11:R45CrossRefPubMedGoogle Scholar
  72. 72.
    Chakrabarti S, Zee JM, Patel KD (2006) Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol 79:214–222CrossRefPubMedGoogle Scholar
  73. 73.
    O’Brian C, Vogel VG, Singletary SE, Ward NE (1989) Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49:3215–3217PubMedGoogle Scholar
  74. 74.
    Blobe GC, Obeid LM, Hannun YA (1994) Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev 13:411–431CrossRefPubMedGoogle Scholar
  75. 75.
    Iakoubov R, Izzo A, Yeung A, Whiteside CI, Brubaker PL (2007) Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 148:1089–1098CrossRefPubMedGoogle Scholar
  76. 76.
    Johnson MD, Torri JA, Lippman ME, Dickson RB (1999) Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp Cell Res 247:105–113CrossRefPubMedGoogle Scholar
  77. 77.
    Aziz MH, Hafeez BB, Sand JM, Pierce DB, Aziz SW, Dreckschmidt NE, Verma Ak (2010) Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 29:3100–3109CrossRefPubMedGoogle Scholar
  78. 78.
    Ellerbroek SM, Hudson LG, Stack MS (1998) Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion. Int J Cancer 78:331–337CrossRefPubMedGoogle Scholar
  79. 79.
    Cox G, Jones JL, O’Byrne KJ (2000) Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res 6:2349–2355PubMedGoogle Scholar
  80. 80.
    Schwartzberg PL (1998) The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene 17:1463–1468CrossRefPubMedGoogle Scholar
  81. 81.
    Liu J, Yue P, Artym VV, Mueller SC, Guo W (2009) The Role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation. Mol Biol Cell 20:3763–3771CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Adriana Soto-Guzman
    • 1
  • Napoleon Navarro-Tito
    • 1
  • Luis Castro-Sanchez
    • 1
  • Raul Martinez-Orozco
    • 1
  • Eduardo Perez Salazar
    • 1
    Email author
  1. 1.Departamento de Biologia CelularCinvestav-IPNMexicoMexico

Personalised recommendations